BRS5-FM1-PM1 — Gut Barrier / Tight Junction Integrity
Stage 2B draft — not approved. Independent Stage 2A/2B review. Canonical science, mappings and review status are unchanged.
1. Mission & Overview
Mission
Maintain epithelial tight junction integrity and selective permeability at the gut lining.
Intervention Dominance: Diet-Supported — Dietary Requirements
- Butyrate
- Fermentable dietary fibre
- Retinoic acid
- Vitamin A
- Zinc
- Glutamine
No additional separately disclosed biochemical participants established; independently adjudicated biochemical roles remain in the atoms above.
- Fermentable fibre resource pool
Overview
The gut lining is a selective gate. Tight junctions, the seals between its cells, control which materials pass between them. Maintaining that selectivity helps protect the body while allowing normal exchange. Butyrate, cellular zinc and retinoid signalling affect epithelial functions in experimental models; glutamine has a condition-specific human permeability result. These findings identify different biological routes rather than a universal gut-repair supplement. [8]
- Benefits: Selective permeability helps limit inappropriate passage across the gut lining; symptom benefits from supplementation are specific to the populations studied.
- Implementation Notes: Fermentable substrates can supply microbial butyrate. Nutrient adequacy differs from extra-intake benefit; the glutamine trial concerned postinfectious diarrhoea-predominant IBS with confirmed hyperpermeability.
- Biological Relevance: This PM concerns epithelial junction regulation. Mucus-specific microbial effects belong to PM3 and bioactive endotoxin containment to PM2. Lower electrical resistance may reflect selective ion permeability rather than unrestricted leakage.
2. Primary Biological Effects
- Intestinal tight-junction structure and regulation determine selective paracellular permeability, while epithelial injury can create a distinct unrestricted permeability pathway. [4]
- Butyrate can function as an epithelial metabolic substrate and promote intestinal tight-junction assembly, while fermentable dietary fibre lies upstream as microbial substrate provision for short-chain-fatty-acid production. [5]
- Current human evidence provides only indirect observational support for a relationship between intestinal barrier biology and attention-related symptoms. [6]
- The bounded evidence assessment does not establish that gut tight-junction integrity modulates Emotional Regulation. [3]
- Cellular zinc supports junction-protein maintenance; retinoic acid influences epithelial differentiation and selective permeability. [8]
- A placebo-controlled trial in postinfectious IBS with hyperpermeability found improved permeability and symptoms with glutamine. [16]
- Specific oligosaccharide and polysaccharide preparations support microbial fermentation upstream of barrier biology. [11]
3. Intervention Levers
No separately adjudicated practice is admitted in this bounded draft. This is not evidence that no practice can affect the mechanism.
No separately adjudicated lifestyle lever is admitted in this bounded draft.
4. Mechanistic Basis
Summary
Cellular zinc supports junction-protein maintenance; retinoic acid influences epithelial differentiation and selective permeability. [8]
Biological process
The zinc result supports a bounded cellular requirement. Retinoid biology cannot be simplified to lower permeability in every context. [8]
Mechanism Boundary
This PM concerns epithelial junction regulation. Mucus-specific microbial effects belong to PM3 and bioactive endotoxin containment to PM2. Lower electrical resistance may reflect selective ion permeability rather than unrestricted leakage.
Integration
This PM contributes its specific process to its parent FM. Shared inputs do not merge distinct jobs or prove an integrated clinical outcome.
4.1 Scientific Findings
Summary
Butyrate and zinc experiments directly interrogate epithelial junction function. Retinoids influence differentiation and permeability, but their direction depends on the model. A selected postinfectious IBS trial found a glutamine response; heterogeneous supplementation evidence does not support a general regimen. Microbiota associations do not establish a barrier-to-cognition effect. [4] [1] [5] [2] [6]
Intestinal epithelial tight junctions form regulated pore and leak pathways that determine selective paracellular passage.
What this means
This supports the PM boundary around epithelial gate function. Downstream microbial-product containment and systemic inflammation remain outside it.
Evidence confidence: Not yet scored
Finding ID: PM1-F1
Finding Statement: Intestinal tight-junction structure and regulation determine selective paracellular permeability, while epithelial injury can create a distinct unrestricted permeability pathway.
Synthesised Evidence Confidence: Not yet scored
Synthesis: An authoritative mechanistic review distinguishes tight-junction-dependent pore and leak pathways from unrestricted flux caused by epithelial damage. In a mouse pneumonia model, increased permeability and claudin-2 were attenuated by oral LGG, providing intervention evidence that barrier permeability and junction-associated biology can move together under pathological conditions.
Synthesis Limitations: The review establishes mechanism rather than dietary responsiveness. The LGG experiment was performed in young mice with experimental Pseudomonas pneumonia, not in healthy humans, and does not establish a generic fermented-food effect.
Evidence Considered:
- Chanez-Paredes and Turner (2023) [4] — Mechanistic — Tight junctions define size- and charge-selective pore and leak pathways; epithelial damage produces a separate unrestricted pathway.
- Khailova et al. (2017) [1] — Animal Data — Oral LGG attenuated pneumonia-induced intestinal permeability and claudin-2 elevation and supported mucin expression in mice.
Microbial fermentation products, especially butyrate, can act directly on epithelial barrier biology.
What this means
This supports a Direct butyrate relationship and a Derived fermentable-fibre provision relationship, with microbiota and fibre-specific limitations.
Evidence confidence: Not yet scored
Finding ID: PM1-F2
Finding Statement: Butyrate can function as an epithelial metabolic substrate and promote intestinal tight-junction assembly, while fermentable dietary fibre lies upstream as microbial substrate provision for short-chain-fatty-acid production.
Synthesised Evidence Confidence: Not yet scored
Synthesis: In Caco-2 monolayers, physiological butyrate increased transepithelial resistance, reduced inulin permeability and accelerated tight-junction assembly alongside AMPK activation. A broader review links microbial fermentation of dietary substrates to short-chain-fatty-acid production and intestinal barrier effects.
Synthesis Limitations: The direct assembly experiment is an immortalised epithelial-cell model. Fibre-to-butyrate conversion varies by fibre structure and microbial ecology, and neither source establishes a universal human intake threshold, a generic effect of all fibre, or oral butyrate as necessary treatment.
Evidence Considered:
- Peng et al. (2009) [5] — Mechanistic — Butyrate increased barrier resistance, reduced inulin permeability and accelerated tight-junction assembly in Caco-2 monolayers.
- Silva et al. (2020) [2] — Mechanistic — The review links microbial fermentation-derived short-chain fatty acids with epithelial barrier and gut-brain communication mechanisms.
Cellular zinc supports junction-protein maintenance; retinoic acid influences epithelial differentiation and selective permeability.
What this means
The zinc result supports a bounded cellular requirement. Retinoid biology cannot be simplified to lower permeability in every context.
Evidence confidence: Not yet scored
Finding ID: PM1-F5
Finding Statement: Cellular zinc supports junction-protein maintenance; retinoic acid influences epithelial differentiation and selective permeability.
Synthesised Evidence Confidence: Not yet scored
Synthesis: The zinc result supports a bounded cellular requirement. Retinoid biology cannot be simplified to lower permeability in every context.
Synthesis Limitations: Cell experiments and mechanistic synthesis do not define dietary thresholds or extra-intake benefit.
Evidence Considered:
- Study
- Intestinal epithelial zinc depletion/repletion experiments.
- Population
- Intestinal epithelial zinc depletion/repletion experiments.
- Result
- Cellular zinc depletion impaired barrier maintenance and affected occludin and claudin-3.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- Cellular zinc depletion impaired barrier maintenance and affected occludin and claudin-3.
- Limitations
- Cellular availability is not proof that ordinary zinc intake limits every person’s barrier.
- Evidence Source
- Bounded external search
- Reference
- [8]
- Study
- Serum-free Caco-2 retinoic-acid exposure.
- Population
- Serum-free Caco-2 retinoic-acid exposure.
- Result
- Differentiation increased, but permeability also increased alongside claudin-2 expression.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- Differentiation increased, but permeability also increased alongside claudin-2 expression.
- Limitations
- A model-specific result; do not infer a universally tighter barrier.
- Evidence Source
- Bounded external search
- Reference
- [14]
- Study
- Attached mechanistic review of vitamin A and intestinal/mucosal biology.
- Population
- Attached mechanistic review of vitamin A and intestinal/mucosal biology.
- Result
- Vitamin A metabolites participate in epithelial differentiation and mucosal regulation.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- Vitamin A metabolites participate in epithelial differentiation and mucosal regulation.
- Limitations
- Review-level support for capacity, not a supplementation trial.
- Evidence Source
- Bounded external search
- Reference
- [7]
- Study
- Retinoid receptor/TLR4 perturbation in Caco-2 cells and vitamin A status experiments in rodents.
- Population
- Retinoid receptor/TLR4 perturbation in Caco-2 cells and vitamin A status experiments in rodents.
- Result
- Retinoid treatment increased junction-related expression and electrical resistance in the tested systems.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- Retinoid treatment increased junction-related expression and electrical resistance in the tested systems.
- Limitations
- Context-specific protective result does not erase the different permeability response in Baltes or establish human supplementation benefit.
- Evidence Source
- Bounded external search
- Reference
- [15]
A placebo-controlled trial in postinfectious IBS with hyperpermeability found improved permeability and symptoms with glutamine.
What this means
Glutamine’s epithelial substrate role and a selected clinical response are compatible; neither establishes a universal dietary shortage. The inherited meta-analysis is heterogeneous and has internally inconsistent dose units, so its subgroup dose is not reproduced.
Evidence confidence: Not yet scored
Finding ID: PM1-F6
Finding Statement: A placebo-controlled trial in postinfectious IBS with hyperpermeability found improved permeability and symptoms with glutamine.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Glutamine’s epithelial substrate role and a selected clinical response are compatible; neither establishes a universal dietary shortage. The inherited meta-analysis is heterogeneous and has internally inconsistent dose units, so its subgroup dose is not reproduced.
Synthesis Limitations: Endogenous supply, illness context and different permeability assays limit generalisation.
Evidence Considered:
- Study
- Postinfectious diarrhoea-predominant IBS with elevated lactulose/mannitol ratio; eight-week placebo-controlled oral glutamine trial.
- Population
- Postinfectious diarrhoea-predominant IBS with elevated lactulose/mannitol ratio; eight-week placebo-controlled oral glutamine trial.
- Result
- The studied glutamine group improved permeability and IBS endpoints relative to placebo.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- The studied glutamine group improved permeability and IBS endpoints relative to placebo.
- Limitations
- Selected disease/hyperpermeability population; not healthy-person efficacy or a general dietary need.
- Evidence Source
- Bounded external search
- Reference
- [16]
- Study
- Attached review of epithelial glutamine biology.
- Population
- Attached review of epithelial glutamine biology.
- Result
- Glutamine supplies enterocyte metabolism and participates in junction maintenance.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- Glutamine supplies enterocyte metabolism and participates in junction maintenance.
- Limitations
- Review-level endogenous dependency is not oral indispensability.
- Evidence Source
- Bounded external search
- Reference
- [9]
- Study
- Attached meta-analysis of heterogeneous adult permeability trials.
- Population
- Attached meta-analysis of heterogeneous adult permeability trials.
- Result
- No significant pooled overall permeability benefit was reported.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- No significant pooled overall permeability benefit was reported.
- Limitations
- Participant-count and mg/g inconsistencies limit dose interpretation; do not copy the subgroup dose as advice.
- Evidence Source
- Bounded external search
- Reference
- [10]
Specific oligosaccharide and polysaccharide preparations support microbial fermentation upstream of barrier biology.
What this means
Retain source-specific provision while separating fermentation measurements from epithelial outcomes.
Evidence confidence: Not yet scored
Finding ID: PM1-F7
Finding Statement: Specific oligosaccharide and polysaccharide preparations support microbial fermentation upstream of barrier biology.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Retain source-specific provision while separating fermentation measurements from epithelial outcomes.
Synthesis Limitations: A supported chain is not proof that each preparation improves human junctions.
Evidence Considered:
- Study
- Controlled FOS/GOS fermentation sampling.
- Population
- Controlled FOS/GOS fermentation sampling.
- Result
- The studied oligosaccharide preparation underwent intestinal fermentation with SCFA handling.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- The studied oligosaccharide preparation underwent intestinal fermentation with SCFA handling.
- Limitations
- No epithelial junction outcome.
- Evidence Source
- Bounded external search
- Reference
- [11]
- Study
- Pectin fermentation with human-derived microbiota.
- Population
- Pectin fermentation with human-derived microbiota.
- Result
- Pectin supported fermentation and SCFA products in vitro.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- Pectin supported fermentation and SCFA products in vitro.
- Limitations
- Often acetate-rich; not uniform butyrate or measured human junction benefit.
- Evidence Source
- Bounded external search
- Reference
- [12]
- Study
- Attached systematic review of resistant starch interventions.
- Population
- Attached systematic review of resistant starch interventions.
- Result
- Responses varied across preparations and participants.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- Responses varied across preparations and participants.
- Limitations
- Faecal SCFA changes do not measure epithelial exposure or a junction effect.
- Evidence Source
- Bounded external search
- Reference
- [13]
5. BRS Pathways and Connections
5.1 BRS Pathways
No newly adjudicated pathway is added by this preview.
5.2 Cross-BRS Mechanism Relationships
Existing connected mechanisms remain candidates in the review history; no new downstream admission is inferred.
5.3 Local BRS Mechanism Relationships
- BRS5-FM1-PM3 — Microbial Barrier–Immune Interface Support: related process for scope comparison; this link does not admit a newly characterised dependency.
- BRS5-FM2-PM5 — SCFA Production & Signalling: related process for scope comparison; this link does not admit a newly characterised dependency.
7. Phenome Connections
No new phenome rating or outcome admission is made in this unapproved draft. Inherited candidate relationships are preserved in the assessment record; microbial, cellular and animal findings do not automatically establish a human cognitive effect.
8. References
- [1] Khailova et al. (2017) — Lactobacillus Rhamnosus GG Treatment Improves Intestinal Permeability and Modulates Inflammatory Response and
- [2] Silva et al. (2020) — Role of Short-Chain Fatty Acids from Gut Microbiota in Gut-Brain Communication
- [3] Jiang et al. (2018) — Gut Microbiota Profiles in Treatment-naïve Children with Attention Deficit Hyperactivity Disorder
- [4] Chanez-Paredes and Turner (2023) — Paracellular Permeability and Tight Junction Regulation
- [5] Peng et al. (2009) — Butyrate and Tight-Junction Assembly
- [6] Özyurt et al. (2018) — Zonulin, Hyperactivity and Social Function
- [7] Cantorna et al. (2019) — Vitamin A, Epithelial Barrier Function and Mucosal Homeostasis
- [8] Miyoshi et al. (2016) — Cellular Zinc and Intestinal Tight-Junction Maintenance
- [9] Rao and Samak (2012) — Glutamine Protection of Intestinal Tight Junctions
- [10] Abbasi et al. (2024) — Glutamine Supplementation and Gut Permeability Meta-analysis
- [11] van Trijp et al. (2024) — Human FOS/GOS Intestinal Fermentation and SCFA Fate
- [12] Pascale et al. (2022) — Pectin Fermentation by Human Gut Microbiota
- [13] Sobh et al. (2022) — Resistant Starch Tolerability and SCFA Production
- [14] Baltes et al. (2004) — All-trans retinoic acid enhances differentiation and influences permeability of intestinal Caco-2 cells under serum-free conditions
- [15] Li et al. (2017) — Retinoic Acid Facilitates Toll-Like Receptor 4 Expression to Improve Intestinal Barrier Function through Retinoic Acid Receptor Beta
- [16] Zhou et al. (2019) — Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome